This is a type of hemangioma that grows inside the brain or spinal cord. It's made of large, thin-walled blood vessels. It often runs in families and can cause problems like seizures, headaches, or stroke.
Every report comes from a Lived member, sent anonymously.
Have you had Craniotomy for Central Nervous System Cavernous Hemangioma?
A central nervous system cavernous hemangioma, more often called a cavernous malformation, cavernoma or cavernous angioma, is a small cluster of abnormal blood vessels in the brain or spinal cord. On a scan it looks something like a raspberry. The vessel walls are thin and weak, so blood moves through them slowly and can seep out into the lesion or the surrounding tissue. Many cavernous malformations never cause problems and are found by chance on a scan done for another reason. When they do cause symptoms, the most common are seizures, a bleed in the brain that acts like a stroke, or new neurological problems such as weakness, numbness, or changes in vision or hearing. Headaches can occur too. In the spinal cord, a lesion is more likely to cause weakness, numbness or pain in the arms or legs, or bladder and bowel problems. Symptoms usually begin between the late teens and the fifties, though children can be affected.
Most cavernous malformations are sporadic: a person has a single lesion, no one else in the family is affected, and it is not passed on to children. These single lesions often sit beside a developmental venous anomaly, a harmless variation in how a vein drains that part of the brain. About one in five people have the familial form, caused by an inherited change in one of three genes (KRIT1, CCM2 or PDCD10). These genes help hold the cells of small blood vessel walls tightly together. People with the familial form usually have several lesions, and new ones can appear over the years. Each child of an affected parent has a 50% chance of inheriting the gene change, although some people who carry it never develop symptoms. In the United States, the familial form is more common in some groups that share a gene change passed down over generations, most notably Hispanic families with roots in the Southwest and northern Mexico. Radiation treatment to the brain, such as for a childhood cancer, can also lead to new cavernous malformations years later.
Magnetic resonance imaging (MRI) is the test that diagnoses a cavernous malformation and is used to follow it over time. A typical lesion has a mixed, popcorn-like center surrounded by a dark ring of old blood. The scan should include a sequence called susceptibility-weighted imaging, which is especially sensitive to traces of old blood and can reveal tiny lesions that standard images miss. That matters because finding one lesion or many changes the likely cause and the plan. A computed tomography (CT) scan is often the first test in an emergency because it quickly shows a large bleed, but it can miss smaller lesions, so MRI usually follows. Cavernous malformations do not show up well on angiograms (dye studies of the blood vessels), so these are rarely needed. A biopsy is not normally used to make the diagnosis. When there are several lesions or other relatives are affected, a blood or saliva test for the three known genes can confirm the familial form. Genetic counseling helps people decide whether and how to test relatives, including children who have no symptoms. A normal MRI does not rule out carrying the family gene change, especially early in life.
A lesion found by chance that has never caused symptoms carries a very low risk of bleeding and generally does not need surgery. Many people are simply watched, with MRI repeated if symptoms appear. Seizures are usually treated first with antiseizure medicines, and about half to 60% of people become seizure-free on medication. When seizures continue despite medicine, or a person cannot tolerate it or wants to stop it, surgery to remove the lesion often controls them; it can also lower the chance of future bleeding from that lesion. Headaches are treated according to their type, and rehabilitation helps people recover from weakness or other deficits after a bleed. Surgical removal is the main treatment for a lesion that has bled, is growing or keeps causing symptoms. Its value depends heavily on location. A lesion near the surface of the brain can often be removed with low risk, and removing a single sporadic lesion is often curative. A lesion deep in the brain or in the brainstem, the part controlling breathing, swallowing and movement, is riskier to reach, so surgeons often wait until it has bled more than once. Stereotactic radiosurgery, which aims focused radiation at the lesion without opening the skull, is sometimes used for lesions too risky to remove, but it controls bleeding less reliably than surgery. Laser ablation through a small opening is a newer option, mainly for seizures. No medicine has yet been proven to shrink lesions or prevent bleeding. Several, including propranolol (a blood pressure medicine also used for skin hemangiomas in infants), are being studied, and clinical trials are an option worth asking about, especially for the familial form.
The outlook varies widely. Many people with a single lesion that has never bled live without symptoms. Once a lesion has bled, the chance of another bleed is higher, though that risk tends to fall over the following few years. Symptoms from a bleed often improve over time, partly or fully, and rehabilitation can help. People with the familial form can develop new lesions over time and usually need lifelong follow-up. How often MRI is repeated is not standardized; it depends on symptoms, past bleeding and the treatment plan. Daily life is often affected less by the lesion itself than by seizures and uncertainty. People with seizures need to follow their state's driving rules, and anxiety is common enough that it is worth raising with the care team. Regular aerobic exercise is considered reasonable, while binge drinking and smoking are best avoided. Some medicines deserve a conversation. Estrogen and progesterone, including birth control pills and hormone therapy, may raise the risk of bleeding, so the choice of contraception or hormone treatment should be discussed. By contrast, having a cavernous malformation is generally not a reason to stop aspirin or another blood thinner that is needed for a heart or clotting condition. Pregnancy does not appear to raise the risk of bleeding, but anyone taking antiseizure medicine should plan pregnancy with their doctor, because some seizure medicines carry risks for the baby and extra folic acid is usually advised. People with the familial form should avoid radiation to the brain where possible.
See a doctor if a scan has shown a cavernous malformation and you have not had a specialist review, or if you have several lesions or a relative with the condition and want to understand genetic testing. Contact your care team promptly about new or gradually worsening symptoms, or seizures that are becoming more frequent, since a repeat MRI may be needed to check for growth or a small bleed. Call 911 or get emergency care for a first seizure, or for sudden symptoms that could mean bleeding in the brain or spinal cord: a sudden severe headache, new weakness or numbness, trouble speaking, a change in vision, or unusual drowsiness or confusion. Brain imaging should be done as soon as possible after these symptoms begin.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Central Nervous System Cavernous Hemangioma is like, what's helped you, or ask the community a question.